Persistent mucocutaneous candidiasis in patients with autoimmune endocrinopathies warrants evaluation for underlying IEI: while candidiasis is common in individuals with diabetes, recurrent or treatment-refractory infections – particularly in the presence of additional autoimmune conditions – should prompt consideration of IEI, including STAT1 gain-of-function mutations. This evidence concerns the gene STAT1 and diabetes mellitus.